CI
PFE icon

Cordant Inc’s Pfizer PFE Stock Holding History

Cordant Inc’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$482 Buy
+20
New +$523 ﹤0.01% 200
2024
Q1 		– Sell
-13
Closed -$375 – 126
2023
Q4 		$375 Buy
+13
New +$393 ﹤0.01% 137
2022
Q2 		– Sell
-464
Closed -$24K – 929
2022
Q1 		$24K Buy
+464
New +$24.1K 0.01% 72
2020
Q1 		– Sell
-415
Closed -$15K – 141
2019
Q4 		$15K Buy
+415
New +$14.8K 0.01% 66

Other funds holding PFE

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
ORIO
Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
KC
Kepler Cheuvreux Nyon $1.75B AUM 37.37% 1-Year Est. Return
WAM
Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

Cordant Inc's PFE Position: Q2 2026 in Review

Cordant Inc opened a new position in Pfizer (PFE) in Q2 2026: 20 shares worth $482. The stake represents ﹤0.01% of the portfolio and ranks #200 among its holdings. This is a return to the name: Cordant Inc previously reported a position in PFE as recently as Q4 2023.

Cordant Inc first reported a position in PFE in Q4 2019 and has held it in 4 quarters since. The position peaked at $24K in Q1 2022. 491 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Cordant Inc held 20 shares of Pfizer worth $482 as of Q2 2026.
  • Pfizer was a new Cordant Inc position in Q2 2026.
  • Pfizer made up ﹤0.01% of Cordant Inc's portfolio in Q2 2026, its #200 holding.
  • Cordant Inc first reported a position in Pfizer in Q4 2019 and has held it in 4 quarters since.
  • Cordant Inc's Pfizer position peaked at $24K in Q1 2022.
  • 491 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Cordant Inc's 13F filing for Q2 2026, filed 15 Jul 2026.